A review of numerous research studies focusing on smoking
cessation has concluded that while women may suffer greater
relative risks of smoking-related diseases than do men,
they tend to have less success than men in quitting
smoking. Dr. Kenneth A. Perkins from the University of
Pittsburgh School of Medicine who conducted the review
offers several reasons for this disparity in a paper
published in the May 2001 issue of "CNS Drugs".
"According to the recent report on women and smoking by the
Surgeon General, three million women have died from
smoking-related diseases since 1980. Currently, women
suffer 39 percent of all smoking related deaths," says NIDA
Director Dr. Alan I. Leshner. "Given the greater relative
risk of women to incur smoking-related diseases, it is
clear that we must find better approaches to help women
break their nicotine addiction."
Dr. Perkins says that one of the intriguing observations
that emerged from his review is that some forms of nicotine
replacement therapy may not be as effective in women as in
men. In some of the studies he reviewed, women had less
treatment success using nicotine gum or nicotine patches
than did men.
In contrast, other stop-smoking medications may more
effective in women than men. Because negative mood is more
likely to precipitate smoking relapse in women than in men,
Dr. Perkins suggests that use of antidepressant medications
for smoking cessation could be more effective in women than
men.
Dr. Perkins concludes that developing smoking cessation
interventions that address the gender-specific concerns of
women smokers could increase the success rate among women
who are trying to stop smoking.
The health risks associated with smoking for both men and
women are well known, and include a two-fold increase in
risks of heart disease and of cancers of the bladder,
stomach, and pancreas, a 10-20 fold increase in lung
cancer, and a 10-fold increase in chronic obstructive
pulmonary disease. Smoking also significantly increases
risks of stroke and pneumonia.
But women may suffer greater relative risks of smoking-
related diseases than do men. For example, in one study
cited by Dr. Perkins in his review, women who smoked had
almost double the risk of myocardial infarction than did
men. The increased risks of heart attack and stroke due to
smoking are further exacerbated in women who also use oral
contraceptives. Some studies have also pointed to the
conclusion that women also may have nearly double the risk
of lung cancer as men.
There is also some evidence that breast cancer risk may be
increased among women who smoke. Smoking is associated
with greater menstrual bleeding and duration of
dysmenorrhea, as well as greater variability in menstrual
cycle length. Women who smoke have a more difficult time
becoming pregnant, and reach menopause on average a year or
two younger than women who do not smoke.
Most health risks associated with smoking are reduced or
eventually eliminated when smoking abstinence is
maintained.